NuVasive® is an innovative global medical device company that is changing spine surgery with minimally disruptive surgical products and procedurally-integrated solutions for the spine. Its mission is to improve the lives of patients who suffer from debilitating back, neck, or leg pain by creating cutting-edge products and procedures that revolutionize spine surgery and achieve superior clinical results.
Through innovative technological advancements, NuVasive has successfully turned major spine surgery into the equivalent of outpatient surgery. Many patients are experiencing extraordinary results—they are often walking the same day of surgery, suffering less blood loss, spending less time in the hospital, and are back to work within four to six weeks (versus six months).
NuVasive offers a comprehensive spine portfolio of more than 90 unique products spanning lumbar, thoracic, and cervical applications, as well as a portfolio of biologics, developed to improve spine surgery and patient outcomes. Its products have been used in hundreds of thousands of spine surgeries. NuVasive is the third largest medical device company in the global spine industry.
NuVasive had revenues of $811 million in 2015, including sales in over 30 countries, and employs more than 1,600 people globally. Corporate headquarters are in San Diego, California and Amsterdam, the Netherlands serves as international headquarters. The company has additional offices in the U.S. located in the states of Tennessee, Ohio, Maryland, and California. Internationally, NuVasive has additional offices located Puerto Rico, the United Kingdom, Germany, Italy, Australia, Spain, Singapore, and Japan.
For more information about NuVasive and spine surgery, visit www.nuvasive.com.